LifeVantage Corporation (LFVN) Q4 2024 Earnings Call Transcript Summary
LifeVantage Corporation (LFVN) Q4 2024 Earnings Call Transcript Summary
Adjusted non-GAAP net income was $1.8 million, or $0.14 per fully diluted share, versus $2.2 million or $0.17 per share a year ago.The following is a summary of the LifeVantage Corporation (LFVN) Q4 2024 Earnings Call Transcript:
以下是LifeVantage Corporation (LFVN) Q4 2024業績會摘要：
Financial Performance:
金融業績：
LifeVantage reported Q4 revenue of $48.9 million, a decrease of 9.8% year-over-year.
Adjusted EBITDA was flat compared to last year in Q4 and totaled $4.8 million, showing consistent operational profitability even amid declining revenue.
Adjusted non-GAAP net income was $1.8 million, or $0.14 per fully diluted share, versus $2.2 million or $0.17 per share a year ago.
Total active accounts decreased by 7.8% impacting revenue, yet revenue per account saw an increase due to changes in product mix and strong sales of TrueScience Liquid Collagen.
LifeVantage報告Q4營業收入爲$4890萬，同比下降9.8%。
Q4調整後的EBITDA與去年持平，總計$480萬，表明即使在營業收入下降的情況下，運營利潤保持穩定。
調整後的非GAAP淨利潤爲$180萬，每股完全攤薄後爲$0.14，而去年同期爲$220萬或每股$0.17。
活躍帳戶總數下降7.8%，對營業收入產生影響，但由於產品組合的變化和TrueScience液體膠原蛋白的強勁銷售，每帳戶營收有所增加。
Business Progress:
業務進展：
Introduced a new GLP-1 based weight management system, set to launch in October, aimed at naturally activating hormone production for weight management.
Refreshed loyalty programs to increase consultant and consumer engagement and retention, integrating with LifeVantage's broader LV360 initiative.
Continued focus on shareholder value via $1.8 million in stock repurchases and issuing a quarterly dividend of $0.04 per share, alongside strong balance sheet maintenance.
推出新的基於GLP-1的體重管理系統，計劃於十月份推出，旨在通過自然激活激素產生來進行體重管理。
更新的忠誠計劃旨在提升顧問和消費者的參與度和留存率，並與lifevantage更廣泛的LV360計劃相結合。
通過180萬美元的股票回購和發放每股0.04美元的季度股息，繼續專注於股東價值，同時保持穩健的資產負債表管理。
Opportunities:
機會：
Anticipating growth from the new GLP-1 weight management product which differentiates by being 100% natural and designed for long-term use.
預計從新GLP-1減重產品中實現增長，該產品與衆不同之處在於百分之百天然且專爲長期使用而設計。
Risks:
風險：
Declining total active accounts put pressure on revenue growth, indicating potential market share challenges and operational risks. Currency fluctuations also pose a financial risk affecting international market sales.
下降的總活躍帳戶對營業收入增長造成壓力，表明可能存在市場份額挑戰和運營風險。貨幣波動也構成影響國際市場銷售的財務風險。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。